Prevalence of Occult Hepatitis B Infection among HBsAg Negative Blood Donors in Golestan Province

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 168

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JIML-6-1_007

تاریخ نمایه سازی: 7 اسفند 1401

چکیده مقاله:

Background and Aims: Occult hepatitis B virus infection (OBI) is known as an important source of hepatitis B virus (HBV) infection. It is categorized as Hepatitis B surface antigen (HBsAg) not being present and low DNA viral load in serum. In this study, an attempt was made to investigate the outbreak of anti-HBc and OBI among the HBsAg-negative donors in Golestan province. Materials and Methods: The present cross-sectional experiment was conducted on ۳۵۰۰ voluntary blood donors in Golestan province to examine the presence of human immunodeficiency viruses Ag-Ab, HBsAg, and hepatitis C virus Ab. Then, samples with negative results for the mentioned tests were screened for total HBc antibody (IgM-IgG) through ELISA technique. Afterward, HBV-DNA extraction and R-T PCR assay were conducted for all HBsAg negative samples by using Real ART HBV LC PCR kit on a Light Cycler instrument. Results: The study participants included ۳۲۵۵ (۹۳%) male and ۲۴۵ (۷%) female. In general, ۳۸۵ (۱۱%) out of ۳۵۰۰ samples were anti-HBc positive. HBV-DNA results for every sample with either positive or negative anti-HBc were found to be negative. Conclusions: As the area under study has a high rate of anti-HBc outbreak (۱۱%) without the presence of HBV-DNA, anti-HBc screening can cause blood donor deferrals and limit blood supply; therefore, the HBsAg test with high analytical sensitivity is recommended for HBV screening in this area. Regarding the cost analyses and also the status of HBV endemicity, HBsAg test along with ID-NAT is preferable, if possible, for improving blood safety.

کلیدواژه ها:

نویسندگان

رعنا تبار اسد

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.

زهره شریفی

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.

علی اکبر پورفتح الله

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.

شهرام سامعی

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • . Sagnelli E, Coppola N. Virologic and clinical expressions of ...
  • . Song JE. Kim DY. Diagnosis of hepatitis B. Ann ...
  • . World Health Organization (WHO). Hepatitis B. Fact sheet n. ...
  • . Shouval D . What is the clinical significance of ...
  • . Donato F, Gelatti U. Southern Europe as an example ...
  • . Merrill RM, Hunter BD. Seroprevalence of markers for hepatitis ...
  • . Liu CJ, Chen DS. Epidemiology of HBV infection in ...
  • . Hoofnagle JH, Seeff LB. Type B hepatitis after transfusion ...
  • . Raimondo G, Allain JP. Statements from the Taormina expert ...
  • . Martine MC, Kok CC. Investigation of occult hepatitis B ...
  • . Arababadi MK, Hassanshahi G. Post transfusion occult hepatitis B ...
  • . Pourazar A, Salehi M. Detection of HBV DNA in ...
  • . Merat S, Malekzadeh R. Hepatitis B in Iran. Arch ...
  • . Alizadeh Z, Milani S. Occult Hepatitis B virus infection ...
  • . Jafarzadeh A, Arababadi MK. Occult hepatitis B virus infection ...
  • . Amini KA, Talebian A. Detection of Hepatitis B Virus ...
  • . Behzad-Behbahni A, Mafi-Nejad A. Anti-HBc & HBV DNA detection ...
  • . Arababadi MK, Pourfathollah AA. Occult HBV infection in Rafsanjanese ...
  • . Sofian M, Aghakhani A. Lack of occult hepatitis B ...
  • . Karimi G, Zadsar M. Prevalence of antibody to Hepatitis ...
  • . Roshandel G, Semnani S. The prevalence of Co-infection with ...
  • . Merat S, Rezvan H. The prevalence of hepatitis B ...
  • . Mosley JW, Stevens CE. Donor screening for antibody to ...
  • . Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: ...
  • . Brechot C, Thiers V. Persistent hepatitis B virus infection ...
  • . Allain JP. Global epidemiology of occult HBV infection. An ...
  • . Bal SH, Heper Y. Investigation of the presence of ...
  • . Arababadi MK, Pourfathollah AA. Serum levels of IL-۱۰ and ...
  • . Panigrahi R, Biswas A. Subgenotype D. BCP and MHR ...
  • . Fayyadh TK , Fuying MA. Hepatitis B Virus DNA ...
  • . Hass M, Hannoun C. Functional analysis of hepatitis B ...
  • نمایش کامل مراجع